Sangamo Therapeutics (SGMO) Q1 2025 Earnings

Mar 17Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.27
-0.17
-0.06
0.04

Details

Expected EPS
-0.09125
Actual EPS
-0.11
Surprise EPS
-0.02
Surprise Percent
-20.55%

Description

⁨Sangamo Therapeutics⁩ (⁦SGMO⁩) has reported earnings of ⁦-0.11⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts